Innate immune and tissue injury pathways

Innate immune and tissue injury pathways encompass the biological processes by which the host detects and responds to cellular damage (DAMPs) and microbial threats (PAMPs) (Matzinger, 2002, Science). These pathways involve various receptors, such as Toll-like receptors (TLRs) and the NLRP3 inflammasome, which trigger the release of pro-inflammatory cytokines like IL-1β and TNF-α (Janeway et al., 2001, Immunobiology). While these responses are critical for initiating tissue repair and clearing infections, their dysregulation can lead to systemic inflammatory response syndrome (SIRS), chronic fibrosis, or autoimmune conditions (Rock & Kono, 2008, Annual Review of Pathology). In drug development, these pathways are targeted by biologics and small molecules designed to neutralize specific cytokines or inhibit intracellular signaling nodes, such as Anakinra for IL-1 signaling (Arend, 2002, Arthritis & Rheumatism). Understanding the balance between protective immunity and pathological inflammation is key to developing effective therapies for conditions ranging from rheumatoid arthritis to acute lung injury (Chen & Nuñez, 2010, Nature Reviews Immunology). Furthermore, the identification of specific Damage-Associated Molecular Patterns (DAMPs) like HMGB1 has opened new avenues for therapeutic intervention in sterile inflammation (Harris et al., 2012, Journal of Internal Medicine). Current research also focuses on the role of these pathways in the tumor microenvironment, where they can either promote or inhibit cancer progression (Grivennikov et al., 2010, Cell).

Other names

Innate immunityDAMP/PAMP signalingInflammatory response pathwaysPattern recognition receptor signalingTissue damage response

Modulation of innate immune signaling through the inhibition of pro-inflammatory cytokines (e.g., TNF, IL-1, IL-6), pattern recognition receptors (e.g., TLRs, NLRP3), or downstream signaling cascades like NF-κB and JAK/STAT (Chen & Nuñez, 2010, Nature Reviews Immunology).